In addition, CD133+/hi or CD44+/hi cells sorted from four different lung cancer cells also showed higher activation of CaMKIIγ than did CD133−/low or CD44−/low cells (Figure 2C & S2A). The gene discussed is PROM1; the disease is lung carcinoma.